Larson Financial Group’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14
Closed -$156 3532
2025
Q1
$156 Buy
14
+2
+17% +$22 ﹤0.01% 2839
2024
Q4
$124 Buy
+12
New +$116 ﹤0.01% 2558

Other funds holding ENFN

Larson Financial Group's ENFN Position: Q2 2025 in Review

Larson Financial Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 14 shares — an estimated $156 sold.

Larson Financial Group first reported a position in ENFN in Q4 2024 and held it in 2 quarters. The position peaked at $156 in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Larson Financial Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Larson Financial Group sold 14 Enfusion, Inc. shares in Q2 2025, an estimated $156.
  • Larson Financial Group first reported a position in Enfusion, Inc. in Q4 2024 and held it in 2 quarters.
  • Larson Financial Group's Enfusion, Inc. position peaked at $156 in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.